Product Code:530486
Published Date: Jul 31,2023
Pages: 112
Region: Global
Category: Medical Devices & Consumables
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to our (LP Information) latest study, the global Organ On Chip market size was valued at US$ 86 million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Organ On Chip is forecast to a readjusted size of US$ 613.2 million by 2029 with a CAGR of 32.4% during review period. The research report highlights the growth potential of the global Organ On Chip market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Organ On Chip are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Organ On Chip. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Organ On Chip market. An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney). In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application. Global organ on chip key players include Emulate, TissUse, Mimetas, CN Bio Innovations, Valo Health, etc. Global top 5 manufacturers hold a share about 58%. North America is the largest market, with a share about 42%, followed by Europe and Asia-Pacific, both have a share about 50 percent. In terms of product, Liver-on-a-chip is the largest segment, with a share about 26%. And in terms of application, the largest application is pharmaceutical & biotechnology companies, followed by academic & research institutes. Key Features: The report on Organ On Chip market reflects various aspects and provide valuable insights into the industry. Market Size and Growth: The research report provide an overview of the current size and growth of the Organ On Chip market. It may include historical data, market segmentation by Type (e.g., Brain-on-a-chip, Liver-on-a-chip), and regional breakdowns. Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Organ On Chip market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs. Competitive Landscape: The research report provides analysis of the competitive landscape within the Organ On Chip market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. Technological Developments: The research report can delve into the latest technological developments in the Organ On Chip industry. This include advancements in Organ On Chip technology, Organ On Chip new entrants, Organ On Chip new investment, and other innovations that are shaping the future of Organ On Chip. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Organ On Chip market. It includes factors influencing customer ' purchasing decisions, preferences for Organ On Chip product. Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Organ On Chip market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Organ On Chip market. The report also evaluates the effectiveness of these policies in driving market growth. Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Organ On Chip market. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Organ On Chip industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Organ On Chip market. Market Segmentation: Organ On Chip market is split by Type and by End User. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value. Segmentation by type Brain-on-a-chip Liver-on-a-chip Kidney-on-a-chip Lung-on-a-chip Heart-on-a-chip Intestine-on-a-chip Vessel-on-a-chip Other Organs Segmentation by end user Pharmaceutical & Biotechnology Companies Academic & Research Institutes Cosmetics Industry Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Emulate Mimetas TissUse Valo Health CN Bio Innovations Hesperos Draper Laboratory Nortis Micronit Microtechnologies B.V. Kirkstall Cherry Biotech SAS Else Kooi Laboratory Altis Biosystems Bi/ond Netri Xona Microfluidics SynVivo, Inc. Beijing Daxiang Biotech